Drug Manufacturers Get the Anti-Counterfeiting Law They Wanted: Now They Must Meet Deadlines

November signing of Drug Quality and Security Act into law sets in motion a deadline-packed three-phase process of establishing tracing and serialization requirements for drug products to protect the U.S. market from counterfeits.